Market Overview

EOS imaging Will Present Its EOS Solution for Patient-Specific Treatment at the Francophone Radiology Days (JFR) Congress in Paris

Share:
  • stereoVIEW, a software dedicated to clinical collaboration and
    patient engagement, and the new EOS online learning platform will be
    demonstrated at EOS Booth #113
  • Results from a study on 3D spine reconstruction using deep learning
    (artificial intelligence) will be presented for the first time

Regulatory News:

EOS imaging (Euronext, FR0011191766 - EOSI - Eligible PEA - SME), a
pioneer in 2D / 3D orthopedic medical imaging, will present its 2D / 3D
collaborative data sharing solution, stereoVIEW, as well as its new
online learning platform at the Francophone Radiology Days (JFR)
Congress, which will take place October 12-15, at the Palais des Congrès
in Paris.

The event allows imaging professionals to discuss the latest
technological and scientific advances in medical imaging and brings
together clinical as well as basic and industry research. This year's
theme will focus on appropriate imaging for targeted and personalized
treatment.

During JFR, EOS® solution will be highlighted in several scientific
sessions and posters on osteoarticular imaging of the lower limbs and
spine. In particular, a presentation by Dr. Laurence Mainard-Simard from
Nancy will highlight first results from a study using a sterEOS
prototype with artificial intelligence, including deep learning
algorithms, for the automatic modeling of a 3D spine in standing
position. The session will be held on Saturday, October 13 at 4:21pm CET
in Room 253.

Furthermore, EOS imaging will specifically highlight its stereoVIEW
application for collaborative sharing of 2D and 3D data between
radiologists, physicians, and patients. StereoVIEW allows 3D models and
clinical parameters to be visualized to share diagnostic and treatment
options with patients and facilitate exchange with referring physicians.

EOS teams will also present its new certified online training platform.
This innovative tool allows physicians and other healthcare
professionals to train on EOS low dose imaging solution, sterEOS 2D / 3D
modeling and analysis, as well as the EOSapps 3D surgical planning
software suite. Training is provided as classical courses and / or
certifications.

"We are pleased to present new and innovative tools to further
enhance the value of the EOS suite in the treatment of osteoarticular
pathologies at JFR. We continue to focus on improving imaging care and
facilitating the work of radiologists as we support the growing adoption
of our solutions," concluded Marie Meynadier, Chief Executive Officer of
EOS imaging.

For more information, visit us at EOS Booth #113, Hall Passy, Level 1 or
feel free to email us at: contact@eos-imaging.com

ABOUT EOS IMAGING

EOS imaging is listed on Compartment C of Euronext Paris
ISIN:
FR0011191766 - Ticker: EOSI

EOS imaging designs, develops and markets EOS®, a major innovative
medical imaging solution dedicated to osteoarticular pathologies and
orthopedics combining equipment and services and targeting a $2B per
year market opportunity. EOS imaging is currently present in 33
countries, including the United States under FDA agreement, Japan, China
and the European Union under CE labelling, through the over 280
installed EOS® platforms representing more than one million patient
exams every year. Revenues were €37.1M in 2017, e.g. a +32% CAGR over
2012-2017. For more information, please visit www.eos-imaging.com.

EOS imaging has been selected to integrate the EnterNext © PEA - PME
150 index, composed of 150 French, listed companies on the Euronext
markets in Paris.

View Comments and Join the Discussion!